A cDNA that encodes an adenylyl cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6
to those of other mamli adenylyl cyclases that have recently been cloned. A noticeable difference between this protein and other adenylyl cyclases was a lengthy aminoterminal region before the first transmembrane span. Transient expression of this cDNA in the human embryonic kidney cell line 293 revealed a 3-fold increase in cAMP production in response to forskolin compared with control transfected cells. In purified plasma membranes from transfected cells, increased adenylyl cyclase activity was also detected, which was susceptible to inhibition by submicromolar Ca2+. Thus, this adenylyl cyclase seems to represent the Ca2+-inhibitable form that is encountered in NCB-20 cells, cardiac tissue, and elsewhere. Its identification should permit a determination of the structural features that determine the mode of regulation of adenylyl cyclase by Ca2+.
Ca2+, acting via calmodulin, has long been known to stimulate adenylyl cyclase in many brain regions (1) (2) (3) (4) . The correspondence between the concentrations of Ca2+ achieved inside cells and those necessary to mediate stimulation of adenylyl cyclase has consolidated the hypothesis that hormones that increase the intracellular concentration of free Ca2+ ([Ca2+] ,) may increase cAMP by this mechanism.
Indeed, a considerable number of reports indicate that neurotransmitters that increase [Ca2W] i also increase cAMP in brain slice preparations (5) (6) (7) , although the precise mechanism has not been proven.
In contrast to the stimulatory effect of Ca2+, acting via calmodulin, on brain adenylyl cyclase, a growing number of reports indicate that low concentrations of Ca2+, independently of calmodulin, inhibit adenylyl cyclase in plasma membranes from various sources. Adenylyl cyclase from pituitary tissue (8) , purified somatotrophs (9), GH3 rat pituitary tumor cells (10) , NCB-20 cells (11), cardiac sarcolemma (12) , platelets (13) , and C6-2B glioma cells (14) is inhibited by the same range of Ca2+ concentrations that stimulates brain adenylyl cyclase. The inhibition achieved is additive with the effects of G1-protein-coupled receptors (8) (9) (10) (11) (12) (13) . In cells, a mouse neuroblastoma-embryonic Chinese hamster brain explant hybrid, inhibition of adenylyl cyclase by Ca2+ occurs not only in plasma membrane preparations, but also in the intact cell, by [Ca2+] 
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Proc. Natl. Acad. Sci. USA 89 (1992) 6717 structions (Amersham) except that a degenerate oligonucleotide primer was used at 5 ,uM in place of the primers supplied. PCR was performed using degenerate oligonucleotide primers at 5 AM as described (22) . The reaction mixture was treated with BamHI and HindIII and electrophoresed in a 2% agarose gel. Products of appropriate size were isolated and cloned into pBS(+) vector (Stratagene). The DNA sequence of clones was determined by the dideoxy method (23) .
Northern Blot Analysis. RNA from various tissues was isolated (21) , electrophoresed through formaldehyde/ agarose gels, and transferred to nitrocellulose membranes. 32P-labeled hybridization probes were prepared by random priming of gel-purified cloned fragments (24). Blots were hybridized as described (25) . cDNA Cloning and Sequencing. An oligo(dT)-primed and a random hexamer-primed NCB-20 cDNA library were prepared using AZAPII as suggested by the manufacturer (Stratagene). The oligo(dT)-primed library (1.1 x 106 recombinants) was screened with a cloned fragment obtained by PCR. Then, the other library (1.1 x 106 recombinants) was screened with 5'-end regions of newly isolated cDNAs. Hybridization was performed using random-primed probes (25). Positive clones were converted into plasmids by in vivo excision as suggested by Stratagene. Dideoxynucleotide sequencing was performed with a modified T7 DNA polymerase (Sequenase, United States Biochemical), on a series of plasmids generated by deletion with exonuclease III and exonuclease VII (26).
Expression in 293 Cells. The DNA fragment containing the complete coding sequence for type V adenylyl cyclase was reconstructed from three cDNA clones and introduced into the mammalian expression vector pCMV-5 (27) , so that the cytomegalovirus promoter of pCMV-5 directed the expression of the putative adenylyl cyclase. The 293 cells were maintained in 13 ml of minimum essential medium with 10% fetal bovine serum, penicillin at 50 ,tg/ml, streptomycin at 50 ,ug/ml, and neomycin at 100 ,ug/ml in plastic flasks (75 cm2).
Transfection was performed by introduction of 26 ,ug of plasmid DNA into the flasks containing 293 cells at -50% confluency as described by Chen and Okayama (28) . The cells were harvested after 48 hr.
Measurement of cAMP Accumulation in Whole Cells. cAMP formation in intact 293 cells was measured according to the method of Evans et al. (29) . Cells were incubated in minimum essential medium (60 min, 37°C) with 2 uCi (74 kBq) of [3H]adenine per 106 cells. Cells were detached with phosphate-buffered saline containing 0.04% EDTA, washed, and suspended in incubation buffer (110 mM NaCl/5.4 mM KCl/0.8 mM MgSO4/1.38 mM CaC12/0.9 mM NaH2PO4/25 mM D-glucose/0.1% bovine serum albumin). After 10 min of equilibration at 37°C, the suspension was divided into 900-,ul aliquots, each containing -9 x 105 cells. Prior to incubation with test compounds, the cells were preincubated for 10 min at 37°C with phosphodiesterase inhibitors (500 ,uM 3-isobutyl-l-methylxanthine and 100 ,uM Ro 20-1724). cAMP accumulation was measured over 2 min and was terminated by addition of 50 ,ul of 100% (wt/vol) trichloroacetic acid. Unlabeled cAMP (100 ,ul, 10 mM) was added, the mixture was centrifuged, and the Adenylyl Cyclase Activity Measurements. Plasma membranes were prepared following lysis of the cells in buffer (2 mM MgCl2/1 mM EDTA/40 mM Tris-HCI, pH 7.4, with protease inhibitors) by discontinuous sucrose gradient centrifugation; material collecting at the 30%/40% sucrose interface was diluted and washed in lysis buffer prior to storage in liquid nitrogen (11). In experiments that examined the effects of Ca2+ and/or calmodulin, membranes were thawed and washed three times in 800 ,uM EGTA/40 mM Tris HC1, pH 7.4, with bovine serum albumin (50 jig/ml) prior to assay (11).
Adenylyl cyclase activity was determined as described (11) at 300C in the presence of either 5 (20) , suggesting that this is a type IV homologue in NCB-20 cells. The third sequence, represented by only 1 clone, was highly homologous (95%) to the corresponding region of the rat type III sequence (18), suggesting that it is a type III homologue in NCB-20 cells. 
cyclases with the highest scores, suggesting that this PCR clone represents a distinct type of adenylyl cyclase.
Northern blot analysis was performed to examine the expression of mRNA corresponding to the type V sequence in several tissues. The type V probe detected a single mRNA of 6.1 kb and also weakly hybridized to 28S rRNA ( Fig. 2A) . mRNA for type V was most abundant in heart but was weakly detectable in brain, intestine, lung, and spleen (Fig. 2B) .
cDNA Cloning of Type V Adenylyl Cyclase. Screening of the oligo(dT)-primed NCB-20 cDNA library with the type V probe yielded one positive clone. Two subsequent cycles of screening of the random-primed library yielded 27 clones. Three overlapping clones (Fig. 3A) were used for DNA sequencing and subsequent reconstruction of the complete coding sequence for type V adenylyl cyclase (Fig. 3B) . A methionine codon at nucleotide position 37 is followed by a stop codon in the same reading frame at position 64. However, a methionine codon at position 96, which is not in frame with the first one, is followed by an open reading frame that encodes a protein of 1165 amino acids and is surrounded by nucleotides characteristic of those found in eukaryotic translation initiation sites (32) .
The hydrophilicity profile (33) of the type V adenylyl cyclase (Fig. 4) resembles those of the other four mammalian enzymes, suggesting that all of these proteins contain two large hydrophobic regions. Each of the hydrophobic regions of the type V adenylyl cyclase contains six putative transmembrane segments (34) , which is a trait common to all of these proteins. A striking difference between type V and the other adenylyl cyclases is that type V has a very long hydrophilic region (149 amino acids) at the amino terminus.
There are eight consensus sequences for N-linked glycosylation sites within the type V amino acid sequence. Three of these, Asn277, Asn790, and Asn875, are located in presumed extracellular segments. One site is located between transmembrane spans 9 and 10 (Asn790). Thus, all of the mammalian adenylyl cyclases so far reported (types I-V) have one or two N-linked glycosylation sites in this region. The other two sites seen in type V are located between transmembrane spans 5 and 6 (Asn277) and between transmembrane spans 11 and 12 (Asn875).
Since adenylyl cyclase activity in NCB-20 cells is inhibited by Ca2+ at physiological concentrations (11), the sequence was searched for an E-F hand motif (35) forskolin treatment. Cells transfected with either pCMV-ACV or pCMV-ACI showed large (2.6-to 2.9-fold) increases by forskolin treatment compared with the control. Basal activity in pCMV-ACI-transfected cells was twice that of the control cells, while pCMV-ACV-transfected cells showed an activity similar to that of the control cells. With PGE1 treatment, pCMV-ACV-transfected cells showed a 1.3-fold increase while pCMV-ACI-transfected cells showed a slight decrease. PGE1 plus forskolin treatment detected a 2.6-fold increase in the activity of the pCMV-ACV-transfected cells, although the pCMV-ACI-transfected cells did not show any change compared with the control.
Adenylyl cyclase activity was directly measured using plasma membranes prepared from the transfected cells (Table 2). The overall activity of cells transfected with either pCMV-ACV or pCMV-ACI showed an -1.5-fold increase over the control, whether the activity was stimulated by guanosine 5'-[/3,y-imido]triphosphate or forskolin.
Finally, the effects of low concentration of Ca2+ on the two adenylyl cyclases were compared in the absence and presence of calmodulin. Activity was measured in purified plasma membranes that had been extensively washed with EGTA to remove endogenous calmodulin in order to evaluate its role in the effects of Ca2+ on the expressed adenylyl cyclase activities. pCMV-ACI-transfected cells demonstrated a 2-fold in- In comparable experiments, the type V and type I adenylyl cyclases were expressed with equal efficiency in whole cells. However, it appeared that the type I enzyme was relatively refractory to hormonal stimulation. Further experiments may determine whether this apparent refractoriness relates to the unanticipated regulation of the type I enzyme by f8y subunits of GTP-binding proteins, which was recently reported (40) .
Most significantly, in plasma membranes from transfected cells, the type V species showed inhibition by Ca2+ in the submicromolar concentration range, as was seen with the adenylyl cyclase activity of the original NCB-20 cells, whereas cells expressing type I adenylyl cyclase showed calmodulin-dependent stimulation by the same range of Ca2+ concentrations. Although previous biochemical evidence (11) had prompted the suggestion that the Ca2+-inhibitable adenylyl cyclase would display a Ca2+-binding site, E-F hand motifs were not detected in the type V sequence. It will be interesting to determine whether novel features can be identified that confer Ca2+-binding properties on this species, as is the case with lipocortin and other high-affinity Ca2+-binding proteins that do not display the E-F hand motif. 
